Overview
Binds to lymphatic vessel receptors, promoting drainage and reducing inflammation in periorbital tissue.
Proposed mechanism
Acetyl tetrapeptide-5 is an analog of thymopoietin, which activates the lymphatic drainage system and reduces fluid accumulation.
What the evidence supports
Human data exists but the trials are small, short-term, or not yet replicated.
Graded Human-limited
Human data that exists but is thin: open-label work, single-arm studies, small cohorts, or observational follow-up without randomisation.
Key citations
Representative primary sources, including results that did not favour the compound.
- [1]
Eyeseryl clinical study
· DOI:10.1111/j.1468-2494.2008.00486.x · 2008
- [2]
Peptides for periorbital area
· DOI:10.1111/jocd.12949 · 2019
- [3]
Eyeseryl clinical study (2008)
· · 0
- [4]
Peptides for periorbital area (2019)
· · 0
Citation records in this build are illustrative placeholders for the design.
Reference information for research purposes. Not medical advice, and not a recommendation to use any compound. Many entries describe substances that are not approved for human use.